Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4446_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
8 Otosclerosis
101
Fig. 8.13 Right ear otosclerosis with the persistent stape-
dial artery (PSA). The posterior half of the footplate is visible (asterisk) and could be exceptionally accessible for fenestration
2. Dizziness or vertigo: it can be due to labyrin­thitis, which is self-limited and resolves within 3–6days [39]. Other factors can cause dizziness like the heating effect of laser, long prosthesis, and depressed footplate fragment [40]. Long-lasting dizziness requires explora­tion to rule out a perilymph stula.
3. Sensorineural hearing loss: less than 1% in experienced hands [41]. It can be caused by perilymph stula, granuloma formation, or very long prosthesis that penetrates deep into the vestibule (Fig.8.14).
4. Perilymph stula: primary perilymph stula occurs just after the fenestration and persists long after, while secondary perilymph stula appears after a period of time of successful sealing. The latter is usually due to the dislo­cation of the prosthesis. Perilymph stula indicates explorative tympanotomy.
5. Reparative granuloma: it is a reactive granula­tion tissue that occurs after the surgery. It can invade the vestibule leading to hearing loss, tinnitus, and dizziness that appear after 7–12days after the surgery. Most of the cases end in a profound permanent sensorineural hearing loss (Fig.8.15).
Fig. 8.14 Reformatted CT-Image along the prosthesis
axis: stapes prosthesis laterally in contact with the long process of incus and the tympanic membrane (empty arrow), medially the long piston of the stapes prosthesis penetrates deep into the vestibule (white arrow). Thickened footplate between the black arrows
Fig. 8.15 Reformatted CT along the prosthesis axis:
hazy condensations around the piston (white arrows) due to the proliferative inammatory tissue of the granuloma. Intravestibular tip of the prosthesis: black arrow
6. Facial palsy: an immediate post stapedectomy facial palsy is usually due to excessive local anesthesia inltration. Delayed palsy is usu­ally due to reactivation of the VZ virus or Bell’s palsy.
7. Otitis media: Rare, but can cause sensorineu­ral hearing loss. The patient should be admit-
102
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
ted to the hospital to receive antibiotics and steroid. Ear packs, if still in the canal, should be removed.
8.9.5.1 Failure inStapes Surgery
Causes of persistent conductive hearing loss
1. Malleus ankylosis
2. Round window otosclerosis
3. Third window Short prosthesis or
4. small diameter prosthesis
5.
Prosthesis abutting fenestration margin
Causes of recurrent conductive hearing loss
1.
Resorptive osteitis of the incus
2. Displacement of the prosthesis New bone formation in
3. the oval window
4.
Obliteration of the round window by otosclerosis
The most common cause to perform revision sta­pes surgery is prosthesis displacement followed by incus erosion.
8.10 Conservative Treatment ofHearing Loss inOtosclerosis
1. Hearing aid.
2. BAHA or middle ear implant.
3. Medical treatment: Given in cases of active
otosclerosis. Signs and symptoms like the presence of Schwartz sign and onset or wors­ening of tinnitus, vertigo, or hearing loss can indicate active disease. The options for medi­cal therapy include:
(a) Sodium Fluoride: change the active lesion
to an inactive lesion.
(b) Bisphosphonates: it induces apoptosis in
osteoclasts, reducing toxic enzymes’ pro­duction secondary to abnormal bone metabolism.
Take-Home Messages
• Otosclerosis typically presents with slowly progressive unilateral or bilateral deafness, tinnitus, and vertigo may also occur.
• The hearing loss encountered in these patients can be conductive, sensorineu­ral, or mixed.
S. Mansour et al.
• In patients with typical clinical features and uncomplicated conductive hearing loss, audiometry tests are mandatory to establish the diagnosis.
• Imaging study is helpful to determine the disease stages and differential diag­nosis, assess associated anatomic abnor­malities, and evaluate postoperative prosthesis status.
References
1. Schuknecht HF, Barber W.Histologic variants in oto­sclerosis. Laryngoscope. 1985;95:1307–17.
2. Altmann F, Glasgold A, Macduff JP. The incidence of otosclerosis as related to race and sex. Ann Otol Rhinol Laryngol. 1967;76:377–92.
3. Cawthorne T. Otosclerosis. J Laryngol Otol. 1955;9:437–56.
4. Precechtel A.Determination of the effect of pregnancy on the activation of otosclerosis. Acta Otolaryngol. 1967;63:121–7.
5. Zehnder AF, Kristiansen AG, Adams JC, Kujawa SG, Merchant SN, McKenna MJ.Osteoprotegrin knockout mouse demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope. 2006;116:201.
6. Sørensen MS, Jørgensen MB, Bretlau P.Drift barri­ers in the postcartilaginous development of the mam­malian otic capsule. Eur Arch Otorhinolaryngol. 1992;249:56–61.
7. Mansour S, Nicolas K, Ahmad HH.Round window otosclerosis: radiologic classication and clinical cor­relations. Otol Neurotol. 2011;32:384–92.
8. Moumoulidis I, Axon P, Baguley D, Reid E.A review on the genetics of otosclerosis. Clin Otolaryngol. 2007;32(4):239–47. Review.
9. Niedermeyer HP, Gantumur T, Neubert WJ, Arnold W. Measles virus and otosclerosis. Adv Otorhinolaryngol. 2007;65:86–92.
10. Yoo TJ. Etiopathogenesis of otosclerosis: a hypoth­esis. Ann Otol Rhinol Laryngol. 1984;93:28–33.
11. Cureoglu S, Schachern PA, Ferlito A, Rinaldo A, Tsuprun V, Paparella MM. Otosclerosis: etiopatho­genesis and histopathology. Am J Otolaryngol. 2006;27(5):334–40.
12. Valvassori GE.Imaging of otosclerosis. Otolaryngol Clin N Am. 1993;26:359–71.
13. Hueb MM, Goycoolea MV, Paparella MM, Oliveira JA. Otosclerosis: the University of Minnesota tem­poral bone collection. Otolaryngol Head Neck Surg. 1991;105:396–405.
14. Schuknecht HF, Kirchner JC.Cochlear otosclerosis: fact or fantasy? Laryngoscope. 1974;84:766–82.
AL GRAWANY
8 Otosclerosis
103
15. van Loon MC, Merkus P, Smit CF, Smits C, Witte BI, Hensen EF. Stapedotomy in cochlear implant candidates with far advanced otosclerosis: a system­atic review of the literature and meta-analysis. Otol Neurotol. 2014;35(10):1707–14.
16. Gristwood RE, Venables WN. Otosclerosis and chronic tinnitus. Ann Otol Rhinol Laryngol. 2003;112:398–403.
17. Sando I, Hemenway WG, Miller DR, Black FO. Vestibular pathology in otosclerosis tempo­ral bone histopathological report. Laryngoscope. 1974;84:593–605.
18. Paparella MM, Chasin WD.Otosclerosis and vertigo. J Laryngol Otol. 1966;80:511–9.
19. Hannley MT. Audiologic characteristics of the patient with otosclerosis. Otolaryngol Clin N Am. 1993;26(3):373–87.
20. Bel J, Causse J, Michaux P, Cézard R, Canut Y, Tapon J.Mechanical explanation of the on-off effect (dipha­sic impedance change) in otospongiosis. Audiology. 1976;15(2):128–40.
21. Lagleyre S, Sorrentino T, Calmels MN, Shin YJ, Escudé B, Deguine O, Fraysse B.Reliability of high­resolution CT scan in diagnosis of otosclerosis. Otol Neurotol. 2009;30(8):1152–9.
22. Révész P, Liktor B, Liktor B, Sziklai I, Gerlinger I, Karosi T.Comparative analysis of preoperative diag­nostic values of HRCT and CBCT in patients with his­tologically diagnosed otosclerotic stapes footplates. Eur Arch Otorhinolaryngol. 2016;273(1):63–72.
23. Ariadna M, Cozma S, Murariu O, Radulescu L, Haba MSC, Vreme RM, Haba D, Iasi/ RO.ECR 2017 diag­nostic value of CBCT in otosclerosis. Poster No 2283;
2017.
24. Fisch U. Stapedotomy versus stapedectomy. Otol Neurotol. 2009;30(8):1166–7.
25. Cremers CW, Beusen JM, Huygen PL. Hearing gain after stapedotomy, partial platinectomy, or total stape­dectomy for otosclerosis. Ann Otol Rhinol Laryngol. 1991;100:959–61.
26. Spandow O, Soderberg O, Bohlin L.Long-term results in otosclerotic patients operated by stapedectomy and stapedotomy. Scand Audiol. 2000;29:186–90.
27. Persson P, Harder H, Magnuson B.Hearing results in otosclerosis surgery after partial stapedectomy, total stapedectomy and stapedotomy. Acta Otolaryngol. 1997;117:94–9.
28. Fisch U. Stapedectomy versus stapedectomy. Am J Otol. 1982;4:112–7.
29. Esquivel CR, Mamikoglu B, Wiet RJ. Long-term results of small fenestra stapedectomy compared with large fenestra technique. Laryngoscope. 2002;112:1338–41.
30. House HP, Hansen MR, Al Dakhail AAA, House JW. Stapedectomy versus stapedotomy: comparison of results with long-term follow-up. Laryngoscope. 2002;112:2046–50.
31. Wegner I, Kamalski DM, Tange RA, Vincent R, Stegeman I, van der Heijden GJ, Grolman W.Laser versus conventional fenestration in stapedotomy for otosclerosis: a systematic review. Laryngoscope. 2014;124(7):1687–93.
32. Yavuz H, Caylakli F, Ozer F, Ozluoglu LN.Reliability of microdrill stapedotomy: comparison with pick sta­pedotomy. Otol Neurotol. 2007;28(8):998–1001.
33. Rosowski JJ, Merchant SN.Mechanical and acous­tic analysis of middle ear reconstruction. Am J Otol. 1995;16:486–97.
34. Huber AM, Ma F, Felix H, Linder T. Stapes pros­thesis attachment: the effect of crimping on sound transfer in otosclerosis surgery. Laryngoscope. 2003;113:853–8.
35. Gierek T, Witkowska M, Zbrowska-Bielska D, Klimczak-Gołab L. Analysis of results of sta­pedotomy in patients with obliterative otosclerosis. Otolaryngol Pol. 2006;60(3):377–83.
36. Vincent R, Sperling NM, Oates J, Jindal M.Surgical ndings and long-term hearing results in 3050 Stapedotomies for primary otosclerosis: a prospective study with the otology-neurotology database. Otol Neurotol. 2006;27:S25–47.
37. Gersdorff M, Nouwen J, Gilain C, Decat M, Betsch C. Tinnitus and otsclerosis. Eur Arch Otorhinolaryngol. 2000;257:314–6.
38. Berling Holm K, Knutsson J, Strömbäck K, Danckwardt Lillieström N, Papatziamos G, Rosenblad A, Von Unge M. Taste disturbance after stapes surgery: an evaluation of frequency, sever­ity, duration, and quality-of-life. Acta Otolaryngol. 2017;137(1):39–43.
39. Birch L, Elbrond O.Stapedectomy and vertigo. Clin Otolaryngol. 1985;10:217–23.
40. Mansour S, Magnan J, Haidar H, etal. Comprehensive and clinical anatomy of the middle ear. Berlin: Springer; 2013. p.49–81.
41. Glasscock ME III, Storper IS, Haynes DS, Bohrer PS. Twenty-ve years of experience with stapedec­tomy. Laryngoscope. 1995;105:899–904.
Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
AbdulsalamAl-Qahtani, ZaidAltamimi, andReniK.Chandran
9
9.1 Introduction
Hearing loss present at birth (congenital hearing loss) is categorized according to the underlying pathology to hereditary (syndromic or non­syndromic), non-hereditary, and idiopathic. Three types of hearing loss can be induced depending on the site of the lesion: conductive, sensorineural, or a combination of both (mixed) [1].
9.2 Neonatal Hearing Screening
Newborn hearing screening programs show that the incidence of congenital hearing loss is 2–4 children per 1000 births, and it is considered as the most frequently occurring birth defect in the US [2, 3]. Mutations in GJB2 account for 50%
A. Al-Qahtani (*) Hamad Medical Corporation, Doha, Qatar
Otology Clinical Fellow, Hamad Medical Corporation, Doha, Qatar e-mail: aalqahtani@hamad.qa
Z. Altamimi Otology Clinical Fellow, Hamad Medical Corporation, Doha, Qatar e-mail:
Zaltamimi@hamad.qa
R. K. Chandran Audiology, Hamad Medical Corporation, Doha, Qatar e-mail: RChandran1@hamad.qa
of people with severe-to-profound congenital autosomal- recessive non-syndromic hearing loss [4].
Neonatal hearing screening programs are available for the early detection of this condi­tion. More than 50% of cases of permanent hearing impairment in childhood can be detected shortly after birth [5]. Using the 1-3-6 model intends to screen all newborns within the first month of birth for early diagnosis and subsequent early management with a better developmental outcome [6]. View the algo­rithm below to check the steps of the screen­ing. However, passing the neonatal screening does not rule out hearing impairment in child­hood. Progressive or late-onset hearing loss can be undetected by neonatal screening pro­grams [6].
© Springer Nature Switzerland AG 2021 A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_9
AL GRAWANY
105
106
A. Al-Qahtani et al.
Neonatal screening
Pass
No Risk Factors
Discharge The Patient
Genetic
testing
Positive Risk Factors
Re-assessment 1 to 4
weeks
Pass
Evaluate for TORCH
infections
Fail
Confirmed Hearing Loss
9.3 Evaluation ofaChild withCongenital Hearing Loss
The general approach to evaluating the child with suspected congenital hearing loss includes the following:
History: pregnancy history, perinatal and
postnatal period, NICU admission, postnatal infection, ototoxic medications, co-existing medical conditions, family history of hearing loss in rst- and second-degree relatives, con­sanguinity, and ethnic origin.
Physical examination: a full head and neck
examination should be performed to includ­ing any dysmorphic features, the shape, and position of the external ears, neck examina-
Fail
Re-assessment 1 to 4 weeks
Pass
Audiology re-assessment
Imaging
studies
Fail
Normal Hearing
Screening other
anomalies
tion for cysts, sinuses, and scars (branchio­oto-renal syndrome), swelling of the thyroid gland (may indicate Pendred syndrome), and unusual pigmentation of the hair, skin, or eyes (which may indicate an auditory pig­mentary disorder).
Investigation: the following should be con-
sidered: genetic testing, CT/MRI imaging, thyroid function tests, cardiology evaluation (Echo and ECG, for possible association with Jervell and Lange-Nielsen syndrome or con­genital heart conditions), or ophthalmology assessment (electroretinogram if suspected Usher syndrome).
Risk factors for permanent congenital, delayed, or progressive hearing loss in childhood are described in Box 9.1 [5].
9 Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Box 9.1 Risk Factors for Permanent Congenital, Delayed or Progressive Hearing Loss in Childhood
• Hearing, speech, language, or developmental delay
Family history of hearing loss Neonatal intensive care unit stay >5days or
• receiving any of the following treatments: extra corporal membrane oxygenation, assisted ventilation, ototoxic drugs (e.g., gentamycin and tobramycin), loop diuretics, or exchange transfusion for hyperbilirubinemia
• In utero infections (toxoplasmosis, rubella, cytomegalovirus, herpes simplex, or syphilis)
Craniofacial anomalies, including ear tags, ear
pits, and anomalies that involve the outer ear, external auditory canal, and temporal bone
Physical ndings associated with a syndrome
• known to cause permanent hearing loss (e.g.,, white forelock)
Syndromes associated with congenital hearing
loss or progressive or late-onset hearing loss
Neurodegenerative disorders or sensorimotor
• neuropathies
Conrmed bacterial or viral meningitis
• Head trauma, especially of the basal skull, or temporal bone fractures that require hospitalization
Chemotherapy
9.4 Categories ofCongenital Hearing Loss
1. Idiopathic (25%).
2. Hereditary (50%):
Non-syndromic (70%): more common,
the prex “DFN” to designate non­syndromic DeaFNess, DFN followed by an A implies dominant inheritance, whereas B implies recessive inheritance and X implies X-linked inheritance. Autosomal recessive (AR) in (75–80%), GJ2B mutation (auto­somal recessive) coding for the protein gap junction beta 2 (also called connexin 26) results in impaired Potassium (K+) exchange. Autosomal dominant (AD) in (20–25%), X-linked in (2–4%), and mito­chondrial in <1% [5].
Syndromic (30%): Divided into AR, AD,
• and X-linked. The most common syn­dromic form of hereditary SNHL is Usher syndrome [7], and other AR syndromes include Pendred syndrome and Jervell and Lange–Nielsen Syndrome. The most com­mon AD syndrome is Waardenburg [7], and others include Treacher–Collins Syndrome (Fig. 9.1), Branchio-oto-renal Syndrome (mainly mixed hearing loss), Neurobromatosis Type 2, and Stickler Syndrome. X-linked includes Alport’s syn­drome. Box
9.2 describes the features of
the most common congenital hereditary hearing loss syndromes.
3. Non-hereditary (25%)
Malformations: arrest in normal develop-
ment may result in hearing impairment depending on the timing and nature of the developmental insult. About 65% of such abnormalities are bilateral, and 35% are unilateral. Malformations include Membranous (Alexander’s Aplasia, Scheibe Deformity, and Siebenmann–Bing Dysplasia) and Osseous and Membranous (Cochlear Hypoplasia, Mondini, Common Cavity, Cochlear Aplasia, Michel Aplasia, and Small Internal Auditory Canal). Mondini malformation is the most com­mon type of cochlear malformation [1].
Alexander aplasia is one of the mem-
branous malformations, where cochlear duct differentiation at the level of the basal coil is limited with resultant effects on the organ of Corti and the ganglion cells. Hearing assessment shows high-frequency sensorineural hearing loss with adequate residual hearing in the low frequencies, and amplication devices can be used.
Scheibe aplasia (cochleosaccular dys-
plasia or Pars Inferior dysplasia) is one of the membranous malformations, and it is a relatively common cochlear malformation. Scala media is compro­mised due to the failure of the organ of Corti development affecting the tecto­rial and the Reissner’s membranes. It is
107
AL GRAWANY
108
A. Al-Qahtani et al.
Fig. 9.1 Treacher–Collins syndrome
reported in Jervell and Lange Nielsen, Usher, and Waardenburg syndromes as well as in congenital rubella infants. Amplication devices with rehabilita­tive intervention are benecial in many of these children.
Michel aplasia is one of the osseous
and membranous malformations, where there is complete agenesis of the petrous portion of the temporal bone resulting in absence of normal inner structures and therefore complete deaf­ness. The developmental arrest occurs early prior to the end of the third gesta­tional week.
Mondini deformity is one of the osse-
ous and membranous malformations, and it is the most common type of cochlear malformation [1]. The devel­opmental arrest occurs at the sixth week of gestation. It presents with an incom­plete partition of the cochlea where it contains only about 1.5 turns with only
the basal coil and absence of the apical modiolus and interscalar septum. Mondini deformity is associated with enlarged vestibular aqueduct and dilated vestibule. It is seen in Pendred, Waardenburg, Treacher–Collins, and CHARGE syndromes, and it is also seen in congenital cytomegalovirus (CMV) infection.
Enlarged Vestibular Aqueduct
Syndrome is dened as a vestibular aqueduct measuring more than 1.5mm on CT scan. It is thought to be one of the most common congenital causes of
sensorineural hearing loss. It presents
with early onset bilateral progressive sensorineural hearing loss. It is associ­ated with Pendred syndrome, vestibular anomalies, Mondini malformation, and other cochlear anomalies. Mainstay of treatment is conservative management, including avoidance of head trauma and contact sports.
9 Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
109
TORCH Infections: It includes
Toxoplasmosis, Other (syphilis, varicella­zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes.
– Cytomegalovirus: the most com-
mon cause of congenital viral deafness [8].
– Mumps: the most common infectious
cause of acquired sensorineural hearing loss.
Other perinatal factors: prematurity, low
birth weight, teratogenic drugs, maternal diabetes, hyperbilirubinemia, and neonatal sepsis.
Box 9.2 Overview of Congenital Hearing Loss Syndromes
Syndrome Features Comments Autosomal recessive Usher syndrome Sensorineural hearing loss, retinitis pigmentosa,
Pendred’s syndrome
Jervell and Lange-Nielsen syndrome Autosomal dominant Waardenburg syndrome
Treacher–Collins syndrome
Branchio-oto­renal (BOR) syndrome
X-linked Alport’s syndrome
and vestibular symptoms Type 1, profound hearing loss, vestibular symptoms, and retinitis pigmentosa beginning in rst decade Type 2, stable mild to severe hearing loss and retinitis pigmentosa in rst to second decade Type 3, progressive hearing loss, variable vestibular symptoms, and variable onset of retinitis pigmentosa Sensorineural hearing loss (severe to profound), goiter, and abnormality of the bony labyrinth (Mondini dysplasia or enlarged vestibular aqueduct) Profound sensorineural hearing loss with prolongation of QT interval, syncopal episodes, and risk of sudden death
Most common type of AD; hair (white forelock
1), eyes (heterochromia iridis)
Type 1, white forelock and dystopia canthorum Type 2, dystopia absent Type 3, upper limb defects Type 4, increased incidence of Hirschsprung’s
disease Conductive hearing loss, underdevelopment of facial bones (malar and zygomatic hypoplasia) with malformed ossicles, microtia, cleft palate; micrognathia, downward slanting eyes, coloboma of the eyelid Hearing loss; preauricular pits; malformed pinnae; Branchial cysts or stulae; renal anomalies (structural malformations to agenesis)
Hematuria with progressive renal failure, progressive late-onset high-frequency sensorineural hearing loss; anterior lenticonus and macular ecks
Commonest cause of deafness with blindness, early diagnosis of retinitis pigmentosa possible with electroretinography, and cochlear implants effective
Iodine transport defect diagnosed by perchlorate discharge test in those homozygous for Pendred’s syndrome (SLC26A4) and euthyroid goiter Should have a thorough cardiac evaluation, carriers also at risk for sudden death, and treatment effective
Hearing loss caused by defective migration of pigment cells to stria vascularis
Results from mutations in 1 of 3 collagen genes expressed in glomerular basement membrane
AL GRAWANY
110
Take-Home Messages
• The most common prenatal cause of hearing loss is intrauterine infection (CMV).
• Mutations in GJB2 account for 50% of severe-to-profound autosomal-recessive non-syndromic deafness.
• The goal of newborn testing is to screen by 1 month of age, diagnose hearing loss by 3 months of age, and initiate intervention by 6months of age.
• Screening based on risk factors only detects 50% of infants with substantial congenital hearing loss.
References
1. Shibata SB, Eliot Shearer A, Richard JH. Genetic sensorineural hearing loss, Chap. 148. In: Cummings otolaryngology: head & neck surgery. 6th ed. Philadelphia: Elsevier; 2015. p.2285–300.
A. Al-Qahtani et al.
2. Parving A. The need for universal neonatal hearing screening–some aspects of epidemiology and identi­cation. Acta Paediatr. 1999;88(432):69–72.
3. White KR. The current status of EHDI programs in the United States. Ment Retard Dev Disabil Res Rev. 2003;9(2):79–88.
4. Smith RJ, Robin NH. Genetic testing for deafness– GJB2 and SLC26A4 as causes of deafness. J Commun Disord. 2002;35(4):367–77.
5. Chi DH, Sabo DL.Pediatric audiology and implant­able hearing device, Chap. 100. In: Bailey’s head and neck surgery: otolaryngology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. p.1507–22.
6. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL.Language of early- and later-identied children with hearing loss. Pediatrics. 1998;102:1161–71.
7. Smith RJH, Shearer AE, Hildebrand MS, et al. Deafness and hereditary hearing loss overview. 1999 Feb 14 [Updated 2014 Jan 9]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2017.
8. Fowler KB, Boppana SB.Congenital cytomegalovi­rus (CMV) infection and hearing decit. J Clin Virol. 2006;35:226.
Sensorineural Hearing Loss (SNHL)
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
AishaLarem, ZaidAltamimi, andAdhamAljariri
10
10.1 Introduction
Hearing loss can be dened as an impairment in the ability to perceive sound stimulus. It includes three types: Conductive, Sensorineural, and Mixed hearing loss. Sensorineural hearing loss (SNHL) occurs due to defect in the sensory appa­ratus of the cochlea (sensory), or the peripheral pathways of conduction of nerve impulses (XIII CN) to the brain or in the central auditory path­way or cortex (neural).
Knowledge of growth, development, and func­tional anatomy of the inner ear is important to be able to identify the pathology and diagnose it. Membranous labyrinth develops from otic plac­ode from the third week of the gestational age (GA) and then it becomes otocysts subdivided into vestibular and cochlear compartments. Cochlea reaches the shape of adult form at 10weeks and adult size at 20weeks GA.Cochlea is composed of a 35mm coiled bony tube with 2.5 turns, and it is divided into scala vestibuli, scala tympani, and scala media. Scala vestibuli and scala tympani contain perilymph, scala media is located between scala vestibuli and tympani, and
A. Larem (*) · Z. Altamimi · A. Aljariri Hamad Medical Corporation, Doha, Qatar e-mail: alarem@hamad.qa; ZAITamimi@hamad.qa;
AAljariri@hamad.qa
it contains the endolymph. Scala media is bounded by Reissner’s membrane, basilar membrane, osse­ous spiral lamina, and stria vascularis in the lateral wall, and it contains the organ of Corti. Organ of Corti is the receptor organ for hearing, composed of outer and inner hair cells, supporting cells, and the tectorial membrane. Inner and outer hair cells are differing in morphology and innervation. Inner hair cells’ neural innervation is by type I neurons which are predominantly afferent neu­rons, where 15–20 of these neurons innervate each inner hair cell. Outer hair cells’ neural syn­apses are by type II neurons which are predomi­nantly efferent, where each type II neuron branches to innervate around ten outer hair cells. Sound transduction is dened as converting sound vibrations (mechanical energy) into neural impulse (electrical energy) by the movement of the basilar membrane with the hair cells against the tectorial membrane, stimulating generation of nerve ending impulses in spiral ganglion. The spi­ral ganglion sends axons into the cochlear nerve. The cochlear nerve transmits auditory informa­tion up a series of nuclei to the auditory cortex where perception occurs. These nuclei include: (1) cochlear nucleus, (2) superior olivary nuclei, (3) lateral lemniscus, (4) inferior colliculus, and (5) medial geniculate nuclei.
Sensorineural hearing loss (SNHL) is fea-
tured with the following
© Springer Nature Switzerland AG 2021 A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_10
AL GRAWANY
111